1,2-dimethylhydrazine multiple interactions ISO RGD:1320905 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SRRM2 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO RGD:1320904 6480464 Estradiol results in decreased expression of SRRM2 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1320905 6480464 Tetrachlorodibenzodioxin affects the expression of SRRM2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SRRM2 mRNA CTD PMID:34747641 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of SRRM2 mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO RGD:1320904 6480464 Lactic Acid results in increased expression of SRRM2 mRNA CTD PMID:30851411 2-methylcholine affects expression ISO RGD:1320904 6480464 beta-methylcholine affects the expression of SRRM2 mRNA CTD PMID:21179406 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1320904 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SRRM2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1320904 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SRRM2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1320905 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of SRRM2 promoter CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:1320905 6480464 Fenretinide results in increased expression of SRRM2 mRNA CTD PMID:28973697 aflatoxin B1 increases expression ISO RGD:1320905 6480464 Aflatoxin B1 results in increased expression of SRRM2 mRNA CTD PMID:19770486 aristolochic acid decreases expression ISO RGD:1320904 6480464 aristolochic acid I results in decreased expression of SRRM2 protein CTD PMID:33212167 arsane affects methylation ISO RGD:1320904 6480464 Arsenic affects the methylation of SRRM2 gene CTD PMID:25304211 arsane multiple interactions ISO RGD:1320904 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SRRM2 protein CTD PMID:35072517 arsenic atom affects methylation ISO RGD:1320904 6480464 Arsenic affects the methylation of SRRM2 gene CTD PMID:25304211 arsenic atom multiple interactions ISO RGD:1320904 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SRRM2 protein CTD PMID:35072517 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SRRM2 mRNA CTD PMID:33854195 benzo[a]pyrene affects expression ISO RGD:1320905 6480464 Benzo(a)pyrene affects the expression of SRRM2 mRNA CTD PMID:22342234 benzo[a]pyrene multiple interactions ISO RGD:1320905 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SRRM2 mRNA CTD PMID:27858113 benzo[a]pyrene increases expression ISO RGD:1320905 6480464 Benzo(a)pyrene results in increased expression of SRRM2 mRNA CTD PMID:20504355 , PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1320904 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 benzo[b]fluoranthene multiple interactions ISO RGD:1320905 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SRRM2 mRNA CTD PMID:27858113 bis(2-chloroethyl) sulfide increases phosphorylation ISO RGD:1320904 6480464 Mustard Gas results in increased phosphorylation of SRRM2 protein CTD PMID:19845377 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SRRM2 mRNA CTD PMID:30816183 bisphenol A increases expression ISO RGD:1320905 6480464 bisphenol A results in increased expression of SRRM2 mRNA CTD PMID:29165653 Brodifacoum decreases expression EXP 6480464 bromfenacoum results in decreased expression of SRRM2 protein CTD PMID:28903499 buspirone increases expression EXP 6480464 Buspirone results in increased expression of SRRM2 mRNA CTD PMID:24136188 butanal decreases expression ISO RGD:1320904 6480464 butyraldehyde results in decreased expression of SRRM2 mRNA CTD PMID:26079696 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SRRM2 mRNA CTD PMID:33453195 carbon nanotube decreases expression ISO RGD:1320905 6480464 Nanotubes more ... CTD PMID:25554681 chloropicrin affects expression ISO RGD:1320904 6480464 chloropicrin affects the expression of SRRM2 mRNA CTD PMID:26352163 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of SRRM2 mRNA CTD PMID:23125180 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SRRM2 mRNA CTD PMID:33854195 choline multiple interactions ISO RGD:1320905 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SRRM2 gene CTD PMID:20938992 chrysene multiple interactions ISO RGD:1320905 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SRRM2 mRNA CTD PMID:27858113 cisplatin decreases expression ISO RGD:1320904 6480464 Cisplatin results in decreased expression of SRRM2 mRNA CTD PMID:27594783 cisplatin increases phosphorylation ISO RGD:1320905 6480464 Cisplatin results in increased phosphorylation of SRRM2 protein CTD PMID:22006019 clozapine decreases expression ISO RGD:1320904 6480464 Clozapine results in decreased expression of SRRM2 protein CTD PMID:34122009 cobalt dichloride decreases expression ISO RGD:1320904 6480464 cobaltous chloride results in decreased expression of SRRM2 mRNA CTD PMID:19320972 cobalt dichloride increases expression ISO RGD:1320904 6480464 cobaltous chloride results in increased expression of SRRM2 mRNA CTD PMID:19376846 copper atom increases expression EXP 6480464 Copper results in increased expression of SRRM2 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of SRRM2 mRNA CTD PMID:30556269 coumestrol increases expression ISO RGD:1320904 6480464 Coumestrol results in increased expression of SRRM2 mRNA CTD PMID:19167446 cyclosporin A increases expression ISO RGD:1320904 6480464 Cyclosporine results in increased expression of SRRM2 mRNA CTD PMID:25562108 deoxynivalenol affects phosphorylation ISO RGD:1320905 6480464 deoxynivalenol affects the phosphorylation of SRRM2 protein CTD PMID:23352502 , PMID:23811945 dexamethasone multiple interactions ISO RGD:1320904 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SRRM2 mRNA CTD PMID:28628672 diazinon increases methylation ISO RGD:1320904 6480464 Diazinon results in increased methylation of SRRM2 gene CTD PMID:22964155 dicrotophos increases expression ISO RGD:1320904 6480464 dicrotophos results in increased expression of SRRM2 mRNA CTD PMID:28302478 dioxygen increases expression ISO RGD:1320905 6480464 Oxygen deficiency results in increased expression of SRRM2 mRNA CTD PMID:24205000 diuron decreases expression EXP 6480464 Diuron results in decreased expression of SRRM2 mRNA CTD PMID:21551480 elemental selenium multiple interactions ISO RGD:1320904 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of SRRM2 mRNA CTD PMID:19244175 enzyme inhibitor multiple interactions ISO RGD:1320904 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SRRM2 protein CTD PMID:23301498 ethanol affects expression ISO RGD:1320905 6480464 Ethanol affects the expression of SRRM2 mRNA CTD PMID:26730594 fenthion decreases expression ISO RGD:1320905 6480464 Fenthion results in decreased expression of SRRM2 mRNA CTD PMID:34813904 folic acid multiple interactions ISO RGD:1320905 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 folic acid decreases expression ISO RGD:1320905 6480464 Folic Acid results in decreased expression of SRRM2 mRNA CTD PMID:25629700 geldanamycin increases expression ISO RGD:1320904 6480464 geldanamycin results in increased expression of SRRM2 mRNA CTD PMID:26705709 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SRRM2 mRNA CTD PMID:22061828 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SRRM2 mRNA CTD PMID:33854195 hexadecanoic acid decreases phosphorylation ISO RGD:1320904 6480464 Palmitic Acid results in decreased phosphorylation of SRRM2 protein CTD PMID:28073184 hydrogen peroxide increases phosphorylation ISO RGD:1320905 6480464 Hydrogen Peroxide results in increased phosphorylation of SRRM2 protein CTD PMID:31494107 hydrogen peroxide multiple interactions ISO RGD:1320905 6480464 [Hydrogen Peroxide co-treated with N-(oxo-5 more ... CTD PMID:31494107 hydrogen peroxide affects expression ISO RGD:1320904 6480464 Hydrogen Peroxide affects the expression of SRRM2 mRNA CTD PMID:21179406 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SRRM2 mRNA CTD PMID:33854195 indometacin multiple interactions ISO RGD:1320904 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SRRM2 mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:1320904 6480464 Ivermectin results in decreased expression of SRRM2 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1320905 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SRRM2 gene CTD PMID:20938992 menadione affects expression ISO RGD:1320904 6480464 Vitamin K 3 affects the expression of SRRM2 mRNA CTD PMID:20044591 methamphetamine increases expression ISO RGD:1320905 6480464 Methamphetamine results in increased expression of SRRM2 mRNA CTD PMID:26307267 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of SRRM2 mRNA CTD PMID:30467583 methidathion decreases expression ISO RGD:1320905 6480464 methidathion results in decreased expression of SRRM2 mRNA CTD PMID:34813904 phenobarbital decreases expression ISO RGD:1320905 6480464 Phenobarbital results in decreased expression of SRRM2 mRNA CTD PMID:23091169 PhIP increases expression ISO RGD:1320904 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of SRRM2 mRNA CTD PMID:20816883 propiconazole decreases expression ISO RGD:1320905 6480464 propiconazole results in decreased expression of SRRM2 mRNA CTD PMID:21278054 quercitrin increases expression ISO RGD:1320904 6480464 quercitrin results in increased expression of SRRM2 mRNA CTD PMID:25193878 rac-lactic acid increases expression ISO RGD:1320904 6480464 Lactic Acid results in increased expression of SRRM2 mRNA CTD PMID:30851411 resveratrol decreases expression ISO RGD:1320905 6480464 resveratrol results in decreased expression of SRRM2 protein CTD PMID:25505154 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of SRRM2 mRNA CTD PMID:25905778 selenium atom multiple interactions ISO RGD:1320904 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of SRRM2 mRNA CTD PMID:19244175 silver atom increases expression ISO RGD:1320905 6480464 Silver results in increased expression of SRRM2 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1320905 6480464 Silver results in increased expression of SRRM2 mRNA CTD PMID:27131904 sodium arsenate decreases expression ISO RGD:1320905 6480464 sodium arsenate results in decreased expression of SRRM2 mRNA CTD PMID:21795629 sodium arsenate increases expression ISO RGD:1320905 6480464 sodium arsenate results in increased expression of SRRM2 mRNA CTD PMID:21795629 sodium arsenite multiple interactions ISO RGD:1320904 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SRRM2 protein CTD PMID:35072517 sunitinib increases expression ISO RGD:1320904 6480464 Sunitinib results in increased expression of SRRM2 mRNA CTD PMID:31533062 temozolomide increases expression ISO RGD:1320904 6480464 Temozolomide results in increased expression of SRRM2 mRNA CTD PMID:31758290 testosterone enanthate affects expression ISO RGD:1320904 6480464 testosterone enanthate affects the expression of SRRM2 mRNA CTD PMID:17440010 tetraphene multiple interactions ISO RGD:1320905 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SRRM2 mRNA CTD PMID:27858113 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SRRM2 mRNA CTD PMID:33854195 thimerosal decreases expression ISO RGD:1320904 6480464 Thimerosal results in decreased expression of SRRM2 mRNA CTD PMID:27188386 titanium dioxide affects expression ISO RGD:1320905 6480464 titanium dioxide affects the expression of SRRM2 mRNA CTD PMID:23557971 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of SRRM2 mRNA CTD PMID:30589522 triptonide increases expression ISO RGD:1320905 6480464 triptonide results in increased expression of SRRM2 mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:1320905 6480464 troglitazone results in decreased expression of SRRM2 mRNA CTD PMID:28973697 trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of SRRM2 mRNA CTD PMID:24136188 tungsten decreases expression ISO RGD:1320905 6480464 Tungsten results in decreased expression of SRRM2 mRNA CTD PMID:30912803 valproic acid decreases expression ISO RGD:1320904 6480464 Valproic Acid results in decreased expression of SRRM2 mRNA CTD PMID:22083351 more ... valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of SRRM2 mRNA CTD PMID:29427782 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of SRRM2 mRNA CTD PMID:20566332 , PMID:23555832 vitamin E decreases expression ISO RGD:1320904 6480464 Vitamin E results in decreased expression of SRRM2 mRNA CTD PMID:19244175 vitamin E multiple interactions ISO RGD:1320904 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of SRRM2 mRNA CTD PMID:19244175 vorinostat decreases expression ISO RGD:1320904 6480464 vorinostat results in decreased expression of SRRM2 mRNA CTD PMID:27188386 xylitol increases expression ISO RGD:1320904 6480464 Xylitol results in increased expression of SRRM2 mRNA CTD PMID:32275922
